AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

13,592.00p
   
  • Change Today:
      78.00p
  • 52 Week High: 14,148.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.73m
  • Volume: 1,461,235
  • Market Cap: £210,775m
  • RiskGrade: 123

Regulatory News

Holding(s) in Company 04-Dec-2025 15:00 RNS
Block listing Interim Review 01-Dec-2025 15:05 RNS
Total Voting Rights 01-Dec-2025 15:00 RNS
Imfinzi approved in US for early gastric cancer 26-Nov-2025 07:00 RNS
AstraZeneca manufacturing investment in Maryland 24-Nov-2025 07:00 RNS
Koselugo (selumetinib) approved in the US 20-Nov-2025 07:00 RNS
Holding(s) in Company 17-Nov-2025 15:00 RNS
Director/PDMR Shareholding 14-Nov-2025 11:00 RNS
Director/PDMR Shareholding 10-Nov-2025 15:00 RNS
9M and Q3 2025 results 06-Nov-2025 07:00 RNS
Result of General Meeting 03-Nov-2025 16:00 RNS
Total Voting Rights 03-Nov-2025 15:00 RNS
Director Declaration 28-Oct-2025 07:05 RNS
Koselugo (selumetinib) approved in the EU 28-Oct-2025 07:00 RNS
Tezspire Approved in EU for CRSwNP 22-Oct-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 13,592.00p
Change Today 78.00p
% Change 0.58 %
52 Week High 14,148.00p
52 Week Low 9,667.00p
Volume 1,461,235
Shares Issued 1,550.73m
Market Cap £210,775m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 05-Dec-2025

Time Volume / Share Price
16:27 0 @ 13,578.00p
16:11 0 @ 13,552.00p
16:11 0 @ 13,552.00p
16:09 0 @ 13,554.00p
16:09 0 @ 13,554.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page